Abnormal IFN-γ-dependent immunoproteasome modulation by Trypanosoma cruzi-infected macrophages

Parasite Immunology

Volumn 30, Issue 5, 2008, Pages 280-292

  Bergeron, M ^a,b   Blanchette, J ^a,b   Rouleau, P ^a,b   Olivier, M ^a,b,c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Macrophages; MHC; Proteasome; Trypanosoma cruzi

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; CELL SURFACE; DOWN REGULATION; IMMUNOMODULATION; MACROPHAGE; NONHUMAN; PARASITE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TRYPANOSOMA CRUZI;

ANIMALS; ANTIGEN PRESENTATION; CHAGAS DISEASE; CYSTEINE ENDOPEPTIDASES; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; MACROPHAGES; MAP KINASE KINASE 4; MICE; MULTIENZYME COMPLEXES; NIH 3T3 CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN TYROSINE PHOSPHATASES; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 41949136660     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2008.01022.x     Document Type: Article

References (82)

1. Coux O, Tanaka K Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996 65 : 801 847.
2. Kloetzel PM. Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2001 2 : 179 187.
3. Sijts AJ, Standera S, Toes RE, et al. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells. J Immunol 2000 164 : 4500 4506.
4. Sijts AJ, Ruppert T, Rehermann B, Schmidt M, Koszinowski U Kloetzel PM. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J Exp Med 2000 191 : 503 514.
5. Schwarz K, van Den Broek M, Kostka S, et al. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 α/β, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope. J Immunol 2000 165 : 768 778.
6. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994 1 : 533 541.
7. Boes B, Hengel H, Ruppert T, Multhaup G, Koszinowski UH Kloetzel PM. Interferon-γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J Exp Med 1994 179 : 901 909.
8. Kuckelkorn U, Frentzel S, Kraft R, Kostka S, Groettrup M Kloetzel PM. Incorporation of major histocompatibility complex - encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-γ. Eur J Immunol 1995 25 : 2605 2611.
9. + proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes. Curr Biol 1995 5 : 923 930.
10. Knuehl C, Spee P, Ruppert T, et al. The murine cytomegalovirus pp89 immunodominant H-2Ld epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide. J Immunol 2001 167 : 1515 1521.
11. Schmidtke G, Eggers M, Ruppert T, Groettrup M, Koszinowski UH Kloetzel PM. Inactivation of a defined active site in the mouse 20S proteasome complex enhances major histocompatibility complex class I antigen presentation of a murine cytomegalovirus protein. J Exp Med 1998 187 : 1641 1646.
12. Groettrup M, Soza A, Eggers M, et al. A role for the proteasome regulator PA28α in antigen presentation. Nature 1996 381 : 166 168.
13. Dick TP, Ruppert T, Groettrup M, et al. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 1996 86 : 253 262.
14. Kuckelkorn U, Ferreira EA, Drung I, Liewer U, Kloetzel PM Theobald M. The effect of the interferon-γ-inducible processing machinery on the generation of a naturally tumor-associated human cytotoxic T lymphocyte epitope within a wild-type and mutant p53 sequence context. Eur J Immunol 2002 32 : 1368 1375.
15. Murata S, Udono H, Tanahashi N, et al. Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β. Embo J 2001 20 : 5898 5907.
16. Sun Y, Sijts AJ, Song M, et al. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells. Cancer Res 2002 62 : 2875 2882.
17. Cascio P, Hilton C, Kisselev AF, Rock KL Goldberg AL. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. Embo J 2001 20 : 2357 2366.
18. Chen W, Norbury CC, Cho Y, Yewdell JW Bennink JR. Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J Exp Med 2001 193 : 1319 1326.
19. Toes RE, Nussbaum AK, Degermann S, et al. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med 2001 194 : 1 12.
20. Shimbara N, Nakajima H, Tanahashi N, et al. Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region. Genes Cells 1997 2 : 785 800.
21. van Hall T, Sijts A, Camps M, et al. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28. J Exp Med 2000 192 : 483 494.
22. Saint-Ruf C, Ungewiss K, Groettrup M, Bruno L, Fehling HJ von Boehmer H. Analysis and expression of a cloned pre-T cell receptor gene. Science 1994 266 : 1208 1212.
23. Luckey CJ, King GM, Marto JA, et al. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J Immunol 1998 161 : 112 121.
24. Gileadi U, Moins-Teisserenc HT, Correa I, et al. Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. J Immunol 1999 163 : 6045 6052.
25. Sewell AK, Price DA, Teisserenc H, et al. IFN-γ exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase. J Immunol 1999 162 : 7075 7079.
26. Morel S, Levy F, Burlet-Schiltz O, et al. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 2000 12 : 107 117.
27. Cerundolo V, Kelly A, Elliott T, Trowsdale J Townsend A. Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur J Immunol 1995 25 : 554 562.
28. Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL Liang TJ. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol 1999 73 : 7231 7240.
29. Vertegaal AC, Kuiperij HB, Houweling A, Verlaan M, van der Eb AJ Zantema A. Differential expression of tapasin and immunoproteasome subunits in adenovirus type 5- versus type 12-transformed cells. J Biol Chem 2003 278 : 139 146.
30. Khan S, van den Broek M, Schwarz K, de Giuli R, Diener PA Groettrup M. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J Immunol 2001 167 : 6859 6868.
31. Barton LF, Cruz M, Rangwala R, Deepe GS Jr. Monaco JJ. Regulation of immunoproteasome subunit expression in vivo following pathogenic fungal infection. J Immunol 2002 169 : 3046 3052.
32. Gavioli R, Gallerani E, Fortini C, et al. HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity. J Immunol 2004 173 : 3838 3843.
33. Haorah J, Heilman D, Diekmann C, et al. Alcohol and HIV decrease proteasome and immunoproteasome function in macrophages: implications for impaired immune function during disease. Cell Immunol 2004 229 : 139 148.
34. Khan S, Zimmermann A, Basler M, Groettrup M Hengel H. A cytomegalovirus inhibitor of γ interferon signaling controls immunoproteasome induction. J Virol 2004 78 : 1831 1842.
35. Khu YL, Tan YJ, Lim SG, Hong W Goh PY. Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity. Biochem J 2004 384 : 401 409.
36. Kingman S. South America declares war on Chagas disease. New Scientist 1991 19 : 16 17.
37. Bittencourt AL. Congenital chagas disease. Am J Dis Child 1976 130 : 97 103.
38. Buckner FS, Wilson AJ, White TC Van Voorhis WC. Induction of resistance to azole drugs in Trypanosoma cruzi. Antimicrob Agents Chemother 1998 42 : 3245 3250.
39. Alwine JC, Kemp DJ Stark GR. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci USA 1977 74 : 5350 5354.
40. Towbin H, Staehelin T Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979 76 : 4350 4354.
41. Ornstein L. Disc electrophoresis-I. Background and theory. Ann NY Acad Sci 1964 121 : 321 349.
42. Davis BJ. Disc electrophoresis-II. Method and application to human serum proteins. Ann NY Acad Sci 1964 121 : 404 427.
43. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227 : 680 685.
44. Zar JH. Biostatistical Analysis, 2nd edn. Englewood Cliffs, New Jersey, Prentice Hall, Inc., 1984.
45. Rice WR. Analyzing tables of statistical tests. Evolution 1989 43 : 223 225.
46. Bergeron M Olivier M. Trypanosoma cruzi-mediated IFN-γ-inducible nitric oxide output in macrophages is regulated by iNOS mRNA stability. J Immunol 2006 177 : 6271 6280.
47. Jaramillo M, Godbout M Olivier M. Hemozoin induces macrophage chemokine expression through oxidative stress-dependent and - independent mechanisms. J Immunol 2005 174 : 475 484.
48. Ropert C, Almeida IC, Closel M, et al. Requirement of mitogen-activated protein kinases and I κB phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide. J Immunol 2001 166 : 3423 3431.
49. Howcroft TK, Richardson JC Singer DS. MHC class I gene expression is negatively regulated by the proto-oncogene, c-jun. Embo J 1993 12 : 3163 3169.
50. Blanchetot C, Tertoolen LG den Hertog J. Regulation of receptor protein-tyrosine phosphatase α by oxidative stress. Embo J 2002 21 : 493 503.
51. Sommer D, Coleman S, Swanson SA Stemmer PM. Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. Arch Biochem Biophys 2002 404 : 271 278.
52. Reed SG, Nathan CF, Pihl DL, et al. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon γ. J Exp Med 1987 166 : 1734 1746.
53. Cardoni RL, Antunez MI, Morales C Nantes IR. Release of reactive oxygen species by phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Am J Trop Med Hyg 1997 56 : 329 334.
54. Griffin TA, Nandi D, Cruz M, et al. Immunoproteasome assembly: cooperative incorporation of interferon γ (IFN-γ) -inducible subunits. J Exp Med 1998 187 : 97 104.
55. Schmidt M, Zantopf D, Kraft R, Kostka S, Preissner R Kloetzel PM. Sequence information within proteasomal prosequences mediates efficient integration of β-subunits into the 20 S proteasome complex. J Mol Biol 1999 288 : 117 128.
56. Dovhey SE, Ghosh NS Wright KL. Loss of interferon-γ inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line. Cancer Res 2000 60 : 5789 5796.
57. Tarleton RL, Koller BH, Latour A Postan M. Susceptibility of β2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 1992 356 : 338 340.
58. + T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. Plos Pathog 2006 2 : e77.
59. + T cells differentiation and proliferation by the timing of increase in the pathogen load. Plos ONE 2007 2 : e393.
60. Ossendorp F, Fu N, Camps M, et al. Differential expression regulation of the α and β subunits of the PA28 proteasome activator in mature dendritic cells. J Immunol 2005 174 : 7815 7822.
61. Foss GS Prydz H. Interferon regulatory factor 1 mediates the interferon-γ induction of the human immunoproteasome subunit multicatalytic endopeptidase complex-like 1. J Biol Chem 1999 274 : 35196 35202.
62. Chatterjee-Kishore M, Wright KL, Ting JP Stark GR. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. Embo J 2000 19 : 4111 4122.
63. Namiki S, Nakamura T, Oshima S, et al. IRF-1 mediates upregulation of LMP7 by IFN-γ and concerted expression of immunosubunits of the proteasome. FEBS Lett 2005 579 : 2781 2787.
64. Janeway CA Jr., Travers P, Walport M Capra JD. Immunobiology: The Immune System in Health and Disease, 4th edn. London, Elsevier Science Ltd Garland Publishing Inc., 1999.
65. Forget G, Gregory DJ Olivier M. Proteasome-mediated degradation of STAT1α following infection of macrophages with Leishmania donovani. J Biol Chem 2005 280 : 30542 30549.
66. Saeftel M, Fleischer B Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect Immun 2001 69 : 2252 2259.
67. Deutschlander N, Vollerthun R Hungerer KD. Histopathology of experimental Chagas disease in NMRI-mice. A long term study following paw infection. Tropenmed Parasitol 1978 29 : 323 329.
68. Stryker GA Nickell SP. Trypanosoma cruzi: exposure of murine cells to live parasites in vitro leads to enhanced surface class I MHC expression which is type I interferon-dependent. Exp Parasitol 1995 81 : 564 573.
69. Buckner FS, Wipke BT Van Voorhis WC. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes. Eur J Immunol 1997 27 : 2541 2548.
70. Control of Chagas disease. Report of a WHO Expert Committee. World Health Organ Tech Rep Series 1991 811 : 1 95.
71. Schrier PI, Bernards R, Vaessen RT, Houweling A van der Eb AJ. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 1983 305 : 771 775.
72. Anderson KP Fennie EH. Adenovirus early region 1A modulation of interferon antiviral activity. J Virol 1987 61 : 787 795.
73. Mullbacher A. Viral escape from immune recognition: multiple strategies of adenoviruses. Immunol Cell Biol 1992 70 : 59 63.
74. Buchmeier NA Cooper NR. Suppression of monocyte functions by human cytomegalovirus. Immunology 1989 66 : 278 283.
75. Browne H, Smith G, Beck S Minson T. A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin. Nature 1990 347 : 770 772.
76. Jennings SR, Rice PL, Kloszewski ED, Anderson RW, Thompson DL Tevethia SS. Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells. J Virol 1985 56 : 757 766.
77. Kohonen-Corish MR, Blanden RV King NJ. Induction of cell surface expression of HLA antigens by human IFN-γ encoded by recombinant vaccinia virus. J Immunol 1989 143 : 623 627.
78. King NJ, Shrestha B Kesson AM. Immune modulation by flaviviruses. Adv Virus Res 2003 60 : 121 155.
79. Kraus E, Schneider-Schaulies S, Miyasaka M, Tamatani T Sedgwick J. Augmentation of major histocompatibility complex class I and ICAM-1 expression on glial cells following measles virus infection: evidence for the role of type-1 interferon. Eur J Immunol 1992 22 : 175 182.
80. Dhib-Jalbut SS Cowan EP. Direct evidence that interferon-β mediates enhanced HLA-class I expression in measles virus-infected cells. J Immunol 1993 151 : 6248 6258.
81. King NJ Kesson AM. Interferon-independent increases in class I major histocompatibility complex antigen expression follow flavivirus infection. J General Virol 1988 69 : 2535 2543.
82. Van Overtvelt L, Andrieu M, Verhasselt V, et al. Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes. Int Immunol 2002 14 : 1135 1144.